SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-068248
Filing Date
2023-08-16
Accepted
2023-08-16 16:41:48
Documents
15
Period of Report
2023-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183708-8k_inmune.htm   iXBRL 8-K 31779
2 AMENDMENT NO. 1 TO AT-THE-MARKET SALES AGREEMENT, DATED AUGUST 16, 2023, BETWEEN ea183708ex1-1_inmune.htm EX-1.1 30903
3 OPINION OF SICHENZIA ROSS FERENCE LLP ea183708ex5-1_inmune.htm EX-5.1 13808
7 GRAPHIC ex5-1_001.jpg GRAPHIC 17925
  Complete submission text file 0001213900-23-068248.txt   290382

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inmb-20230816.xsd EX-101.SCH 3018
5 XBRL LABEL FILE inmb-20230816_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inmb-20230816_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT ea183708-8k_inmune_htm.xml XML 3410
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 231178708
SIC: 2836 Biological Products, (No Diagnostic Substances)